From Daniel Park on Twitter:
https://x.com/Daniel_E_Park/status/1857633675308896585
"A trio of Novavax preprints, showing 1) remarkable durability >6 months, 2) cross protection against newer variants, and 3) low reactogenicity (side effects), supporting NVX as an excellent booster platform."
https://x.com/Daniel_E_Park/status/1857633675308896585
"A trio of Novavax preprints, showing 1) remarkable durability >6 months, 2) cross protection against newer variants, and 3) low reactogenicity (side effects), supporting NVX as an excellent booster platform."
Comments
https://www.medrxiv.org/content/10.1101/2024.11.07.24316930v1
https://www.medrxiv.org/content/10.1101/2024.11.07.24316865v1
https://www.medrxiv.org/content/10.1101/2024.11.07.24316926v1